 The "Agreements on Conformity Assessment and Acceptance of Industrial Products" (ACAA)  which focus on pharmaceutical products were adopted by the European Parliament on 23 October 2012, following a debate that had lasted for more than two years.Ratification of the ACAA will make it easier to export Israeli pharmaceuticals and other goods to the 27 EU member countries, and "vice versa".Following a controversial debate, 379 members of the European Parliament voted in favor and 230 against ratification.